Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pengo

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 13, 2013
β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functionsN Pozzi, L Acquasaliente, R Frasson, et al.
Lupus|May 29, 2012
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndromeA Banzato, R Frasson, L Acquasaliente, et al.
Thrombosis Research|May 11, 2016
OC-15 - Risk factors for cancer development after idiopathic venous thromboembolismB Cosmi, C Legnani, A Ghirarduzzi, et al.
International Journal of Cardiology|November 5, 2020
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registryP Gresele, G Guglielmini, M Del Pinto, et al.
Lancet (London, England)|August 17, 1996
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant TherapyG Palareti, N Leali, S Coccheri, et al.
Giornale Italiano Di Cardiologia|March 1, 1997
[Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)]G Palareti, N Leali, S Coccheri, et al.
Journal of Thrombosis and Thrombolysis|July 27, 2012
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort studyG Denas, S Padayattil Jose, P Gresele, et al.
Circulation|May 28, 2009
Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management studyV Pengo, U Cucchini, G Denas, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
Clinical course of high-risk patients diagnosed with antiphospholipid syndromeV Pengo, A Ruffatti, C Legnani, et al.
Thrombosis and Haemostasis|January 10, 1998
Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy)G Palareti, C Manotti, A DAngelo, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Haemostasis : JTH|April 13, 2013
β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functionsN Pozzi, L Acquasaliente, R Frasson, et al.
Lupus|May 29, 2012
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndromeA Banzato, R Frasson, L Acquasaliente, et al.
Thrombosis Research|May 11, 2016
OC-15 - Risk factors for cancer development after idiopathic venous thromboembolismB Cosmi, C Legnani, A Ghirarduzzi, et al.
International Journal of Cardiology|November 5, 2020
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registryP Gresele, G Guglielmini, M Del Pinto, et al.
Lancet (London, England)|August 17, 1996
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant TherapyG Palareti, N Leali, S Coccheri, et al.
Giornale Italiano Di Cardiologia|March 1, 1997
[Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)]G Palareti, N Leali, S Coccheri, et al.
Journal of Thrombosis and Thrombolysis|July 27, 2012
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort studyG Denas, S Padayattil Jose, P Gresele, et al.
Circulation|May 28, 2009
Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management studyV Pengo, U Cucchini, G Denas, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
Clinical course of high-risk patients diagnosed with antiphospholipid syndromeV Pengo, A Ruffatti, C Legnani, et al.
Thrombosis and Haemostasis|January 10, 1998
Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy)G Palareti, C Manotti, A DAngelo, et al.
Pageof 17